| MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 1.4K |
| Clinical studies with curcumin | Advances in Experimental Medicine and Biology | 2007 | 259 |
| Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy | Journal of Controlled Release | 2007 | 197 |
| Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial | Investigational New Drugs | 2007 | 92 |
| Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL | Cancer Research | 2007 | 83 |
| Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells | Clinical Cancer Research | 2007 | 81 |
| Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma | Hepatology | 2007 | 78 |
| Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer | BJU International | 2007 | 76 |
| Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years | Cancer | 2007 | 75 |
| Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein | Journal of Pineal Research | 2007 | 66 |
| Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer | Annals of Oncology | 2007 | 37 |
| Endoplasmic reticulum stress is involved in arsenite-induced oxidative injury in rat brain | Toxicology and Applied Pharmacology | 2007 | 35 |
| Using γ-irradiation to synthesize Ag nanoparticles | Materials Letters | 2007 | 33 |
| Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study | Anti-Cancer Drugs | 2007 | 29 |
| Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma | Journal of Urology | 2007 | 24 |
| Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens | Urology | 2007 | 22 |
| Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling | British Journal of Cancer | 2007 | 21 |
| Prognostic factors in extrapulmonary small cell carcinomas. A large retrospective study | Oncology | 2007 | 18 |
| Comparison of the phosphorylation of 4'-ethynyl 2',3'-dihydro-3'-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs | Antimicrobial Agents and Chemotherapy | 2007 | 15 |
| Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression | Journal of Pathology | 2007 | 14 |
| Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result | Liver International | 2007 | 12 |
| Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan | Japanese Journal of Clinical Oncology | 2007 | 12 |
| Proinflammatory macrophage migratory inhibition factor and interleukin-6 are concentrated in pleural effusion of human fetuses with prenatal chylothorax | Prenatal Diagnosis | 2007 | 10 |
| Esophageal adenocarcinoma arising from Barrett's epithelium in Taiwan | Journal of the Formosan Medical Association | 2007 | 10 |
| Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment? | Journal of Surgical Oncology | 2007 | 9 |
